$117.83
-0.49(-0.41%)
Mkt Cap $6.6B
$108.89
$172.26
52-Week Range
At A Glance
1
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.
2
Revenue is primarily driven by Filtration Products (55.7%) and Chromatography Products (20.1%).
3
Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 6, (2026-01-06).
$6.6B
Market Cap
$736M
Revenue
$49M
Net Income
Employees1,778
Fundamentals
How The Business Makes Money
Revenue by Segment
Filtration Products55.7%($1.1B)
Chromatography Products20.1%($403M)
Proteins Products13.7%($275M)
Process Analytics Products9.8%($197M)
Other Products0.6%($12M)
Royalty0%($940.0K)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000730272
ISINUS7599161095
CUSIP759916109
Phone781 250 0111
AddressBuilding 1, Waltham, MA, 02453, US
SEC EDGAR